[Federal Register Volume 86, Number 19 (Monday, February 1, 2021)]
[Notices]
[Pages 7730-7731]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02037]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Tenth Meeting of the National Clinical Care Commission

AGENCY: Office on Women's Health, Office of the Assistant Secretary for 
Health, Office of the Secretary, Department of Health and Human 
Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Clinical Care Commission (the Commission) will 
conduct its tenth meeting virtually on February 17, 2021. The 
Commission is charged to evaluate and make recommendations to the U.S. 
Department of Health and Human Services (HHS) Secretary and Congress 
regarding improvements to the coordination and leveraging of federal 
programs related to diabetes and its complications.

DATES: The meeting will take place on February 17, 2021, from 1 p.m. to 
approximately 5:30 p.m. Eastern Standard time (EST).

ADDRESSES: The meeting will be held online via webinar. To register to 
attend the meeting, please visit the registration website at: https://kauffmaninc.adobeconnect.com/nccc_feb_2021/event/event_info.html.

FOR FURTHER INFORMATION CONTACT: 
Clydette Powell, M.D., MPH, FAAP, Acting Designated Federal Officer, 
National Clinical Care Commission, U.S. Department of Health and Human 
Services Office on Women's Health, 200 Independence Ave. SW, 7th Floor, 
Washington, DC 20201, Phone: (240) 453-8239, Email: [email protected].

SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act 
(Pub. L. 115-80) requires the HHS Secretary to establish the National 
Clinical Care Commission. The Commission consists of representatives of 
specific federal agencies and non-federal individuals who represent 
diverse disciplines and views. The Commission will evaluate and make 
recommendations to the HHS Secretary and Congress regarding 
improvements to the coordination and leveraging of federal programs 
related to diabetes and its complications.
    The tenth meeting will be held virtually, will consist of updates 
from the Commission's three subcommittees, and include another round of 
potential ``action plans,'' or recommendations, from each subcommittee. 
The final meeting agenda will be available prior to the meeting at: 
https://health.gov/our-work/health-care-quality/national-clinical-care-commission/meetings.
    Public Participation at Meeting: The Commission invites public 
comment on

[[Page 7731]]

issues related to the Commission's charge. There will be an opportunity 
for limited oral comments (each no more than 3 minutes in length) at 
this virtual meeting. Virtual attendees who plan to provide oral 
comments at the Commission meeting during a designated time must 
register prior to the meeting at: https://kauffmaninc.adobeconnect.com/nccc_feb_2021/event/event_info.html.
    Written comments are welcome throughout the entire development 
process of the Commission's work and may be emailed to [email protected]. 
Written comments should not exceed three pages in length.
    Individuals who need special assistance, such as sign language 
interpretation or other reasonable accommodations, should indicate the 
special accommodation when registering online or by notifying Jennifer 
Gillissen at [email protected] by February 8, 2021.
    Authority: The National Clinical Care Commission is authorized by 
the National Clinical Care Commission Act (Pub. L. 115-80). The 
Commission is governed by provisions of the Federal Advisory Committee 
Act (FACA), Public Law 92-463, as amended (5 U.S.C., App.) which sets 
forth standards for the formation and use of federal advisory 
committees.

    Dated: January 25, 2021.
Dorothy A. Fink,
Deputy Assistant Secretary for Women's Health, Office of the Assistant 
Secretary for Health.
[FR Doc. 2021-02037 Filed 1-29-21; 8:45 am]
BILLING CODE 4150-32-P